StonvexLoading…
StonvexStonvexStonvexCore line items from PRIM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.56B | $7.57B | $2.18B | $1.89B |
Operating Income | $24.40M | $411.50M | $334.01M | $197.01M |
Net Income | $17.40M | $274.90M | $94.60M | $84.30M |
EPS (Diluted) | $0.32 | $5.02 | $1.73 | $1.54 |
Total Assets | $4.21B | $4.41B | $4.65B | $4.54B |
Total Liabilities | $2.53B | $2.73B | $3.02B | $3.00B |
Cash & Equivalents | $361.50M | $535.50M | $431.42M | $390.25M |
Free Cash Flow OCF − CapEx | $-150.40M | $340.50M | $219.36M | $70.92M |
Shares Outstanding | 54.24M | 54.05M | 54.03M | 54.01M |